期刊文献+
共找到882篇文章
< 1 2 45 >
每页显示 20 50 100
Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis:A multicenter study in Japan 被引量:9
1
作者 Hiroaki Yasuda Keisho Kataoka +25 位作者 Yoshifumi Takeyama Kazunori Takeda Tetsuhide Ito Toshihiko Mayumi Shuji Isaji Tetsuya Mine Motoji Kitagawa Seiki Kiriyama Junichi Sakagami Atsushi Masamune Kazuo Inui Kenji Hirano Ryukichi Akashi Masamichi Yokoe Yoshio Sogame Kazuichi Okazaki Chie Morioka Yasuyuki Kihara Shigeyuki Kawa Masao Tanaka Akira Andoh Wataru Kimura Isao Nishimori Junji Furuse Isao Yokota Tooru Shimosegawa 《World Journal of Gastroenterology》 SCIE CAS 2019年第1期107-117,共11页
BACKGROUND Rapid urinary trypsinogen-2 dipstick test and levels of urinary trypsinogen-2 and trypsinogen activation peptide(TAP)concentration have been reported as prognostic markers for the diagnosis of acute pancrea... BACKGROUND Rapid urinary trypsinogen-2 dipstick test and levels of urinary trypsinogen-2 and trypsinogen activation peptide(TAP)concentration have been reported as prognostic markers for the diagnosis of acute pancreatitis.AIM To reconfirm the validity of all these markers in the diagnosis of acute pancreatitis by undertaking a multi-center study in Japan.METHODS Patients with acute abdominal pain were recruited from 17 medical institutions in Japan from April 2009 to December 2012.Urinary and serum samples were collected twice,at enrollment and on the following day for measuring target markers.The diagnosis and severity assessment of acute pancreatitis were assessed based on prognostic factors and computed tomography(CT)Grade of the Japanese Ministry of Health,Labour,and Welfare criteria.RESULTS A total of 94 patients were enrolled during the study period.The trypsinogen-2 dipstick test was positive in 57 of 78 patients with acute pancreatitis(sensitivity,73.1%)and in 6 of 16 patients with abdominal pain but without any evidence of acute pancreatitis(specificity,62.5%).The area under the curve(AUC)score of urinary trypsinogen-2 according to prognostic factors was 0.704,which was highest in all parameter.The AUC scores of urinary trypsinogen-2 and TAP according to CT Grade were 0.701 and 0.692,respectively,which shows higher than other pancreatic enzymes.The levels of urinary trypsinogen-2 and TAP were significantly higher in patients with extended extra-pancreatic inflammation as evaluated by CT Grade.CONCLUSION We reconfirmed urinary trypsinogen-2 dipstick test is useful as a marker for the diagnosis of acute pancreatitis.Urinary trypsinogen-2 and TAP may be considered as useful markers to determine extra-pancreatic inflammation in acute pancreatitis. 展开更多
关键词 Acute pancreatitis Trypsinogen activation peptide urinary trypsinogen-2 dipstick test
暂未订购
Urinary trypsinogen-2 for diagnosing acute pancreatitis:a meta-analysis 被引量:5
2
作者 Tao Jin Wei Huang +5 位作者 Kun Jiang Jun-Jie Xiong Ping Xue Muhammad A Javed Xiao-Nan Yang Qing Xia 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2013年第4期355-362,共8页
BACKGROUND: Currently, serum amylase and lipase are the most popular laboratory markers for early diagnosis of acute pancreatitis with reasonable sensitivity and specificity. Urinary trypsinogen-2 (UT-2) has been incr... BACKGROUND: Currently, serum amylase and lipase are the most popular laboratory markers for early diagnosis of acute pancreatitis with reasonable sensitivity and specificity. Urinary trypsinogen-2 (UT-2) has been increasingly used but its clinical value for the diagnosis of acute pancreatitis and post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis has not yet been systematically assessed. DATA SOURCES: A comprehensive search was carried out using PubMed (MEDLINE), Embase, and Web of Science for clinical trials, which studied the usefulness of UT-2 as a diagnostic marker for acute pancreatitis. Sensitivity, specificity and the diagnostic odds ratios (DORs) with 95% confidence interval (CI) were calculated for each study and were compared with serum amylase and lipase. Summary receiver-operating curves were conducted and the area under the curve (AUC) was evaluated. RESULTS: A total of 18 studies were included. The pooled sensitivity and specificity of UT-2 for the diagnosis of acute pancreatitis were 80% and 92%, respectively (AUC=0.96, DOR=65.63, 95% CI: 31.65-139.09). The diagnostic value of UT-2 was comparable to serum amylase but was weaker than serum lipase. The pooled sensitivity and specificity for the diagnosis of post-ERCP pancreatitis were 86% and 94%, respectively (AUC=0.92, DOR=77.68, 95% CI: 24.99-241.48).CONCLUSIONS: UT-2 as a rapid test could be potentially used for the diagnosis of post-ERCP pancreatitis and to an extent, acute pancreatitis. Further studies are warranted to confirm these results. 展开更多
关键词 urinary trypsinogen-2 acute pancreatitis endoscopic retrograde cholangiopancreatography diagnostic odds ratios META-ANALYSIS
暂未订购
Use of the urinary trypsinogen-2 dipstick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP)
3
作者 Hasan El-Garem Enas Hamdy +3 位作者 Sherif Hamdy Mohammad El-Sayed Aisha Elsharkawy Azmi Mohammed Saleh 《Open Journal of Gastroenterology》 2013年第6期289-294,共6页
Background: Acute pancreatitis is one of the most serious complications of ERCP. Early diagnosis of post ERCP pancreatitis helps physicians to provide intensive care and possible medical treatment as early as possible... Background: Acute pancreatitis is one of the most serious complications of ERCP. Early diagnosis of post ERCP pancreatitis helps physicians to provide intensive care and possible medical treatment as early as possible. Trypsinogen-2 in urine is a good diagnostic and prognostic marker of acute pancreatitis. Objectives: To evaluate the diagnostic value of urinary trypsinogen-2 dipstick test for early diagnosis of post ERCP pancreatitis. Methods: A total of 37 patients with obstructive jaundice were tested with the urinary trypsinogen-2 dipstick test and serum levels of amylase and lipase before ERCP and 6 hours after ERCP. Results: Post ERCP pancreatitis was diagnosed in 6 (16%) of 37 patients. The sensitivity, specificity, positive predictive value and negative predictive value of urinary trypsinogen-2 dipstick test at 6 hours after ERCP were 100%, 97%, 86%, 100% respectively. At the cutoff level (130 U/L) for lipase, the positive predictive value and negative predictive value all were (100%), however, the positive predictive value and negative predictive value for amylase levels at cutoff (122 U/L) were 60%, 100% respectively. Serum lipase level was the best test for diagnosing post ERCP pancreatitis followed by the urinary trypsinogen-2 dipstick test. Conclusions: The urinary trypsinogen-2 dipstick test can be used as a rapid and easy test for early diagnosis of post ERCP pancreatitis with high sensitivity and specificity. 展开更多
关键词 ERCP PANCREATITIS urinary trypsinogen-2 DIPSTICK TEST
暂未订购
Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis 被引量:21
4
作者 Jesús Sáez Juan Martínez +6 位作者 Celia Trigo José Sánchez-Payá Luis Compay Raquel Laveda Pilar Grió Cristina García Miguel Pérez-Mateo 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第46期7261-7265,共5页
AIM: To assess the usefulness of urinary trypsinogen-2 test strip, urinary trypsinogen activation peptide (TAP),and serum and urine concentrations of the activation peptide of carboxypeptidase B (CAPAP) in the diagnos... AIM: To assess the usefulness of urinary trypsinogen-2 test strip, urinary trypsinogen activation peptide (TAP),and serum and urine concentrations of the activation peptide of carboxypeptidase B (CAPAP) in the diagnosisof acute pancreatitis.METHODS: Patients with acute abdominal pain and hospitalized within 24 h after the onset of symptoms were prospectively studied. Urinary trypsinogen-2 was considered positive when a clear blue line was observed (detection limit 50 μg/L). Urinary TAP was measured using a quantitative solid-phase ELISA, and serum and urinary CAPAP by a radioimmunoassay method.RESULTS: Acute abdominal pain was due to acute pancreatitis in 50 patients and turned out to be extrapancreatic in origin in 22 patients. Patients with acute pancreatitis showed significantly higher median levels of serum and urinary CAPAP levels, as well as amylase and lipase than extrapancreatic controls. Median TAP levels were similar in both groups. The urinary trypsinogen-2 test strip was positive in 68% of patients with acute pancreatitis and 13.6% in extrapancreatic controls (P<0.01). Urinary CAPAP was the most reliable test for the diagnosis of acute pancreatitis (sensitivity 66.7%, specificity 95.5%, positive and negative predictive values 96.6% and 56.7%, respectively), with a 14.6 positive likelihood ratio for a cut-off value of 2.32 nmol/L.CONCLUSION: In patients with acute abdominal pain,hospitalized within 24 h of symptom onset, CAPAP in serum and urine was a reliable diagnostic marker of acute pancreatitis. Urinary trypsinogen-2 test strip showed a clinical value similar to amylase and lipase.Urinary TAP was not a useful screening test for the diagnosis of acute pancreatitis. 展开更多
关键词 Acute pancreatitis urinary trypsinogen-2 urinary trypsinogen activation peptide Activation peptide of carboxypeptidase B Acute abdominal pain
暂未订购
膀胱癌患者血清CEA、CA19-9、β2-MG水平与预后的相关性分析
5
作者 孟佳丽 林海 孟伟 《医学临床研究》 2026年第1期69-72,共4页
【目的】探讨膀胱癌患者血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和β2-微球蛋白(β2-MG)水平与患者预后的相关性。【方法】检测106例膀胱癌患者(观察组),85例体检健康者(对照组)的血清CEA、CA19-9、β2-MG水平,分析其与膀胱癌患者预... 【目的】探讨膀胱癌患者血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和β2-微球蛋白(β2-MG)水平与患者预后的相关性。【方法】检测106例膀胱癌患者(观察组),85例体检健康者(对照组)的血清CEA、CA19-9、β2-MG水平,分析其与膀胱癌患者预后的关系及患者死亡的危险因素。【结果】观察组术前、术后的CEA、CA19-9、β2-MG水平高于对照组,且观察组患者术前CEA、CA19-9、β2-MG水平高于术后(均P<0.05)。随访36个月,106例膀胱癌患者中63例存活(生存组),43例死亡(死亡组)。死亡组TNM分期Ⅲ~Ⅳ期、肿瘤低分化的比例,以及CEA、CA19-9、β2-MG表达水平均高于生存组(P<0.05)。Logistic多因素回归分析结果显示,TNM分期Ⅲ~Ⅳ期、肿瘤低分化,CEA、CA19-9、β2-MG高表达均是膀胱癌患者死亡的危险因素(P<0.05)。CEA、CA19-9、β2-MG高表达组的3年生存率均显著低于低表达组(P<0.05)。【结论】膀胱癌患者血清CEA、CA19-9、β2-MG水平与患者的预后密切相关,其可作为预测膀胱癌患者预后的指标。 展开更多
关键词 膀胱肿瘤 癌胚抗原 CA19-9抗原 Β2微球蛋白 预后
原文传递
老年2型糖尿病患者血清asprosin、UACR与左心室舒张功能障碍的相关性研究
6
作者 陈蕾 李丽 葛静 《国际检验医学杂志》 2026年第3期279-283,289,共6页
目的探讨老年2型糖尿病(T2DM)患者血清白脂素(asprosin)、尿白蛋白与肌酐比值(UACR)与左心室舒张功能障碍(LVDD)的相关性。方法选取2022年8月至2024年7月江阴市第三人民医院收治的128例老年T2DM患者为病例组,另取60例体检健康者为健康... 目的探讨老年2型糖尿病(T2DM)患者血清白脂素(asprosin)、尿白蛋白与肌酐比值(UACR)与左心室舒张功能障碍(LVDD)的相关性。方法选取2022年8月至2024年7月江阴市第三人民医院收治的128例老年T2DM患者为病例组,另取60例体检健康者为健康组。根据LVDD诊断标准,将T2DM患者分为障碍组(n=35)和非障碍组(n=93),并对其进行单因素分析、多因素Logistic回归分析及Spearman相关分析,探讨T2DM患者血清asprosin、UACR与LVDD的相关性,并采用受试者工作特征曲线评估血清asprosin、尿UACR对LVDD的预测效能。结果病例组血清asprosin、尿UACR高于健康组(P<0.05),LVDD组和非LVDD组年龄、病程、血清asprosin、UACR比较,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,年龄≥75岁、病程长、UACR升高、血清asprosin升高均为T2DM发生LVDD的独立危险因素(P<0.05)。Spearman相关分析显示,LVDD与血清asprosin、UACR呈正相关(r=0.551、0.559,均P<0.05)。血清asprosin、尿UACR及预测模型预测LVDD的曲线下面积分别为0.848、0.896、0.956。结论老年T2DM患者血清asprosin、尿UACR与LVDD密切相关,二者联合检测有助于LVDD的早期诊断。 展开更多
关键词 老年2型糖尿病 左心室舒张功能障碍 白脂素 尿白蛋白肌酐比值
暂未订购
尿ACE2和PAX2在先天性肾脏及尿路畸形早期肾损伤辅助诊断中的应用
7
作者 于跑 朱峰 +3 位作者 王子 张印 葛争 周碧 《实用医学杂志》 北大核心 2026年第1期139-145,共7页
目的 探讨尿液血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)和配对盒基因2(paired box gene 2,PAX2)蛋白在先天性肾脏及尿路畸形(congenital anomalies of the kidney and urinary tract,CAKUT)患儿中的表达水平及其与急... 目的 探讨尿液血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)和配对盒基因2(paired box gene 2,PAX2)蛋白在先天性肾脏及尿路畸形(congenital anomalies of the kidney and urinary tract,CAKUT)患儿中的表达水平及其与急性肾损伤(acute kidney injury,AKI)的关联,评估二者作为CAKUT早期肾损伤生物标志物的诊断价值。方法 纳入266例CAKUT患儿(年龄1~18岁),根据KDIGO标准分为CAKUT合并AKI组(n=68)和CAKUT无AKI组(n=198),并匹配健康对照组(n=45)。采用酶联免疫吸附法检测晨尿中ACE2和PAX2水平,结合肾功能指标(血肌酐、e GFR等)进行统计学分析。通过ROC曲线评估诊断效能,Pearson相关分析探究标志物与eGFR的相关性。结果 CAKUT合并AKI组尿ACE2和PAX2水平显著高于CAKUT无AKI组及健康组,且随AKI分期加重呈阶梯式上升(P<0.01)。CAKUT无AKI组与健康对照组间差异无统计学意义(P>0.05)。ACE2和PAX2均与e GFR呈负相关(r=-0.72,P<0.01;r=-0.805,P<0.01)。ACE2单独诊断AUC为0.917(截断值177.8 ng/mg Cr,敏感度80.9%,特异度86.4%);PAX2单独诊断AUC为0.853(截断值11.1 pg/mg Cr,敏感度80.3%,特异度76.1%);联合检测AUC提升至0.956(敏感度88.2%,特异度87.9%),显著优于单一指标(P<0.01)。结论 尿液ACE2与PAX2可用于辅助诊断CAKUT并发急性肾损伤,且诊断效能良好。 展开更多
关键词 先天性肾脏及尿路畸形 血管紧张素转换酶2 配对盒基因2 急性肾损伤 生物标志物
暂未订购
2-Methylnaphthalene as a risk factor for urinary tract infections in patients with early rheumatoid arthritis
8
作者 Hao-Hui Wang Liang Zou +4 位作者 Hao Xu Lu-Xu Yin Si-Bin Zhen Hai-Yan Ma Yan Zhao 《Biomedical Engineering Communications》 2025年第1期34-41,共8页
Background:Studies have shown that individuals who receive early treatment for rheumatoid arthritis(RA)are more likely to approach life positively,avoiding joint damage and the need for joint replacement surgery.The d... Background:Studies have shown that individuals who receive early treatment for rheumatoid arthritis(RA)are more likely to approach life positively,avoiding joint damage and the need for joint replacement surgery.The diagnosis of early rheumatoid arthritis(ERA)is crucial for effective treatment and prognosis of patients.Urine,as a diagnostic medium,offers the advantages of non-invasive diagnosis.Urinary metabolites can serve as biomarkers for diagnosis,prognosis,and risk prediction,improving specificity and accuracy.Methods:We recruited 37 ERA patients with a history of less than 3 months and a score of 6,26 osteoarthritis(OA)patients,and 30 healthy controls(HC).Urine samples were collected for 16S rRNA sequencing,and untargeted liquid chromatography-mass spectrometry(LC-MS)was used to detect metabolites.Bioinformatics approaches were employed to identify pathogenic metabolites as specific risk factors for ERA precisely.Results:2-methylnaphthalene was identified as a biomarker for ERA in urine.Prevotella,a major part of the urinary microbiome in ERA patients,exhibited a positive correlation with 2-methylnaphthalene.Notably,there were significant variations in urine metabolites among patients with ERA,OA,and HC.2-Methylnaphthalene was found to be significantly enriched in ERA.Besides,inflammatory factors were elevated in ERA patients.The research further demonstrated a positive correlation between rheumatoid factor(RF),erythrocyte sedimentation rate(ESR),and C-reactive protein(CRP)and the metabolite 2-methylnaphthalene.Conclusion:The urine metabolite 2-methylnaphthalene can be a risk factor for early urinary tract infections and may contribute to accurately screening early-risk metabolites in ERA. 展开更多
关键词 2-METHYLNAPHTHALENE PREVOTELLA rheumatoid arthritis rheumatoid factors urinary tract infection
暂未订购
Does Prenatal SARS-CoV-2 Infection Exacerbate Postpartum Lower Urinary Tract Symptoms?A Multicenter Retrospective Cohort Study
9
作者 Yuhan Lyu Min Li +8 位作者 Huiqing Yao Tianzi Gai Lin Liang Su Pan Pingping Li Yaxin Liang Yue Yu Xiaomei Wu Min Li 《Biomedical and Environmental Sciences》 2025年第9期1095-1104,共10页
Objective Coronavirus disease 2019(COVID-19)can result in fatigue and post-exertional malaise;however,whether severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection exacerbates lower urinary tract sympto... Objective Coronavirus disease 2019(COVID-19)can result in fatigue and post-exertional malaise;however,whether severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection exacerbates lower urinary tract symptoms(LUTS)is unclear.This study investigated the association between prenatal SARS-CoV-2 infection and postpartum LUTS.Methods A multicenter,retrospective cohort study was conducted at two tertiary hospitals in China from November 1,2022,to November 1,2023.Participants were classified into infected and uninfected groups based on SARS-CoV-2 antigen results.LUTS prevalence and severity were assessed using self-reported symptoms and the Incontinence Impact Questionnaire-Short Form(IIQ-7).Pelvic floor muscle activity was measured using electromyography following the Glazer protocol.Group comparisons were performed to evaluate the association of SARS-CoV-2 infection with LUTS and electromyography parameters,with stratified analyses conducted using SPSS version 26.0.Results Among 3,652 participants(681 infected,2,971 uninfected),no significant differences in LUTS prevalence or IIQ-7 scores were observed.However,SARS-CoV-2 infection was an independent factor influencing the electromyographic activity of the pelvic floor muscles(mean tonic contraction amplitudes),regardless of delivery mode(P=0.001).Conclusion Prenatal SARS-CoV-2 infection was not significantly associated with an increased risk of postpartum LUTS but independently altered pelvic floor muscle electromyographic activity,suggesting potential neuromuscular effects. 展开更多
关键词 COVID-19 post-acute sequelae Lower urinary tract symptoms SARS-CoV-2 ELECTROMYOGRAPHY
暂未订购
Effect of lattice CO_(2)laser combined with Kegel exercise mild moderate stress urinary incontinence and postpartum depression anxiety
10
作者 Zhao-Xia Lou Shu-Ying Huang +3 位作者 Ze-Qiu Wan Yun Chen Hua-Ying Shan Ling-Yan Wang 《World Journal of Psychiatry》 2025年第3期166-174,共9页
BACKGROUND Postpartum stress urinary incontinence(SUI)symptoms affect a patient’s daily activities and quality of life and increase the negative emotions that they experience.At present,there is no research on the ef... BACKGROUND Postpartum stress urinary incontinence(SUI)symptoms affect a patient’s daily activities and quality of life and increase the negative emotions that they experience.At present,there is no research on the effect of fractional CO_(2)laser treatment combined with Kegel exercise on postpartum SUI and postpartum depression and anxiety.AIM To investigate the effect of lattice CO_(2)laser treatment combined with Kegel exercise on mild to moderate postpartum SUI and its influence on postpartum depression and anxiety.METHODS Using a retrospective study,data from 82 cases of mild to moderate postpartum SUI in Huzhou Maternal&Child Health Care Hospital from January to April 2024 were retrospectively collected.The cases were divided into groups according to the different treatment methods,namely Group S(41 cases,only receiving lattice CO_(2)laser treatment)and Group L(41 cases,receiving lattice CO_(2)laser combined with Kegel exercise treatment).The baseline data of the two groups were compared.In addition,we analyzed and compared the scores of the international commission on urinary incontinence questionnaire short form(ICI-Q-SF),incontinence quality of life questionnaire(I-QOL),Edinburgh postnatal depression scale(EPDS),and postpartum specific anxiety scale(PSAS)before treatment,at the end of treatment,and 3 months after the end of treatment between the two groups.Furthermore,the clinical efficacy and adverse reactions of the two groups were analyzed and compared at the end of treatment and 3 months after the end of treatment.RESULTS There was no significant difference in the baseline data and the ICI-Q-SF,I-QOL,EPDS,and PSAS scores between the two groups before treatment.However,at the end of treatment,the ICI-Q-SF,I-QOL,EPDS,and PSAS scores between Groups L and S were significantly different.The overall effective rate of treatment in Group L was significantly higher than that in Group S.During the 3-month follow-up after treatment,it was found that the ICIQ-SF,EPDS,and PSAS scores of Group L were still lower than those of Group S.In comparison,the I-QOL score and total effective rate of treatment were still higher in Group L than those in Group S,and this difference was significant.There was no significant difference in the adverse reactions between Group L and Group S.CONCLUSION The combination of dot lattice CO_(2)laser and Kegel exercise has a significant therapeutic effect on mild to moderate postpartum SUI.It can prolong the duration of therapeutic effects,improve a patient’s quality of life,and alleviate postpartum depression and anxiety. 展开更多
关键词 Lattice CO2laser Kegel exercise Postpartum stress urinary incontinence Depression ANXIETY
暂未订购
2型糖尿病患者TCBI与尿白蛋白/肌酐比值的相关性及临床意义
11
作者 丁艺 尚东胜 +3 位作者 邓霞 王林仙 卜寒莉 庄琴 《临床误诊误治》 2026年第2期41-48,共8页
目的探讨2型糖尿病(T2DM)患者三酰甘油(TG)-总胆固醇(TC)-体质量(BW)指数(TCBI)与尿白蛋白/肌酐比值(UACR)的相关性及临床意义。方法选择2018年1月至2023年11月就诊的T2DM患者600例,收集患者一般资料及TG、TC、UACR等指标。将受试者依... 目的探讨2型糖尿病(T2DM)患者三酰甘油(TG)-总胆固醇(TC)-体质量(BW)指数(TCBI)与尿白蛋白/肌酐比值(UACR)的相关性及临床意义。方法选择2018年1月至2023年11月就诊的T2DM患者600例,收集患者一般资料及TG、TC、UACR等指标。将受试者依据计算出的TCBI值分为低TCBI组、中TCBI组和高TCBI组,每组200例;依据UACR分为正常白蛋白尿组314例、微量白蛋白尿组232例和大量白蛋白尿组54例。应用Pearson相关性分析T2DM患者TCBI与临床特征相关性。多因素Logistic回归分析T2DM患者发生白蛋白尿的危险因素,并评估TCBI对白蛋白尿发生风险的预测价值。结果高TCBI组lgUACR高于低、中TCBI组,中TCBI组对数转化后尿白蛋白/肌酐比值(lgUACR)高于低TCBI组(P<0.05)。大量白蛋白尿组TCBI水平高于正常及微量白蛋白尿组,微量白蛋白尿组高于正常白蛋白尿组(P<0.05)。TCBI与年龄(r=-0.14,P<0.01)、病程(r=-0.11,P<0.01)、高密度脂蛋白胆固醇(r=-0.12,P<0.01)呈负相关,与lgUACR(r=0.27,P<0.01)、体质量指数(r=0.30,P<0.01)、糖化血红蛋白(r=0.12,P<0.01)、空腹血糖(r=0.19,P<0.01)、低密度脂蛋白胆固醇(r=0.23,P<0.01)、血尿素(r=0.09,P<0.01)、血尿酸(r=0.25,P<0.01)、对数转化后胰岛素抵抗指数(r=0.14,P<0.01)呈正相关。多因素Logistic回归分析显示,TCBI为T2DM患者发生白蛋白尿的独立危险因素(P<0.01)。TCBI预测T2DM患者发生白蛋白尿曲线下面积为0.715,敏感度为63.6%,特异度为71.0%。结论在T2DM患者中,TCBI升高与UACR升高相关,增加了白蛋白尿发生的风险,且对白蛋白尿的发生具有一定预测价值。 展开更多
关键词 2型糖尿病 白蛋白尿 三酰甘油 总胆固醇 体质量 营养指数 尿白蛋白/肌酐比值 糖尿病肾病
暂未订购
钠-葡萄糖共转运蛋白2抑制剂对IgA肾病尿蛋白影响的回顾性研究
12
作者 虎璇 陈铖 苏可 《实用药物与临床》 2026年第2期102-108,共7页
目的探讨钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)对IgA肾病(IgAN)尿蛋白的影响及用药安全性。方法回顾性筛选2019年9月至2024年6月在武汉大学人民医院肾内科经肾活检诊断为IgAN且24 h尿蛋白定量为0.3~3.5 g、估算肾小球滤过率(eGFR)≥30 mL... 目的探讨钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)对IgA肾病(IgAN)尿蛋白的影响及用药安全性。方法回顾性筛选2019年9月至2024年6月在武汉大学人民医院肾内科经肾活检诊断为IgAN且24 h尿蛋白定量为0.3~3.5 g、估算肾小球滤过率(eGFR)≥30 mL/(min·1.73m^(2))的患者。根据治疗方法分为SGLT2i联合肾素-血管紧张素系统抑制剂(RASi)组(观察组,n=22)和RASi组(对照组,n=34)。主要观察指标为6个月内尿蛋白变化,次要观察指标为24个月内eGFR斜率变化,比较两组疗效及不良反应。结果治疗6个月后,观察组与对照组患者的24 h尿蛋白定量、24 h尿蛋白较基线下降百分比均显示出随时间下降的趋势(P<0.05),但两组差异无统计学意义(P>0.05)。在治疗6个月末,观察组和对照组24 h尿蛋白定量总缓解率分别为63.64%和29.41%,两组差异有统计学意义(P<0.05)。而在末次随访时,两组24 h尿蛋白定量总缓解率分别为59.09%和47.06%,差异无统计学意义(P>0.05)。在基线24 h尿蛋白定量≥1.0 g或基线eGFR≥90 mL/(min·1.73m^(2))亚组中,治疗6个月后,观察组尿蛋白缓解程度均优于对照组(P<0.05),但末次随访时,两组差异无统计学意义(P>0.05)。观察组总eGFR斜率略低于对照组,但两组差异无统计学意义(P>0.05)。两组患者均未出现严重不良反应。结论与单用RASi相比,SGLT2i联合RASi用药可显著提高IgA肾病患者治疗6个月时的尿蛋白总缓解率,尤其是在基线24 h尿蛋白≥1.0 g或eGFR≥90 mL/(min·1.73m^(2))的患者中获益更为明确。联合治疗方案显示出延缓eGFR长期下降趋势的潜力,且未增加安全风险。 展开更多
关键词 IGA肾病 钠-葡萄糖共转运蛋白2抑制剂 肾素-血管紧张素系统抑制剂 估算肾小球滤过率 24h尿蛋白
暂未订购
基于MDA、AOPP、HO-1、和肽素水平变化分析头孢呋辛治疗老年2型糖尿病合并泌尿道感染的效果
13
作者 付亿玲 高玉涛 +1 位作者 梁瑞凯 卢旭东 《分子诊断与治疗杂志》 2026年第1期127-130,共4页
目的探讨头孢呋辛对老年2型糖尿病(T2DM)合并泌尿道感染(UTI)患者丙二醛(MDA)、晚期蛋白氧化产物(AOPP)、血红素氧化酶1(HO-1)、和肽素水平及症状改善的影响。方法研究对象选取2020年4月至2024年4月于河北省第八人民医院接受治疗的老年T... 目的探讨头孢呋辛对老年2型糖尿病(T2DM)合并泌尿道感染(UTI)患者丙二醛(MDA)、晚期蛋白氧化产物(AOPP)、血红素氧化酶1(HO-1)、和肽素水平及症状改善的影响。方法研究对象选取2020年4月至2024年4月于河北省第八人民医院接受治疗的老年T2DM合并UTI患者,共纳入110例,分为A组(55例)和B组(55例),分组方法为随机数字表法。A组给予左氧氟沙星,B组在A组基础上给予头孢呋辛钠。两组均持续治疗7 d。比较两组治疗7 d后的临床疗效,治疗前、治疗7 d后的临床症状评分、免疫功能、MDA、AOPP、HO-1、和肽素水平,治疗期间的不良反应。结果B组治疗7 d后的总有效率高于A组,差异有统计学意义(P<0.05)。与治疗前比较,治疗7 d后,两组临床症状评分及血清MDA、AOPP、HO-1、和肽素水平均降低,且相比于A组,B组更低,差异有统计学意义(P<0.05);两组外周血CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)水平均升高,且相比于A组,B组更高,差异有统计学意义(P<0.05)。两组治疗期间的不良反应发生率比较没有统计学意义(P>0.05)。结论头孢呋辛可有效促进老年T2DM合并UTI患者症状改善,提高患者免疫功能,减轻患者炎症反应及氧化应激反应,进而提高临床疗效,且安全性良好。 展开更多
关键词 2型糖尿病 泌尿道感染 老年 头孢呋辛
暂未订购
血尿酸、尿微量白蛋白、血肌酐水平联合检测预测T2DM患者发生糖尿病肾病的价值
14
作者 陈田 吴梦冉 吕亚坤 《中国民康医学》 2026年第5期129-131,共3页
目的:分析血尿酸、尿微量白蛋白、血肌酐水平联合检测预测2型糖尿病(T2DM)患者发生糖尿病肾病(DN)的价值。方法:选取2023年3月至2024年3月该院收治的104例T2DM患者的临床资料,根据是否发生DN将其分为未发生组(n=63)和发生组(n=41),另选... 目的:分析血尿酸、尿微量白蛋白、血肌酐水平联合检测预测2型糖尿病(T2DM)患者发生糖尿病肾病(DN)的价值。方法:选取2023年3月至2024年3月该院收治的104例T2DM患者的临床资料,根据是否发生DN将其分为未发生组(n=63)和发生组(n=41),另选取同期该院65名健康体检者为对照组。比较三组血尿酸、尿微量白蛋白、血肌酐水平,绘制受试者工作特征(ROC)曲线,分析血尿酸、尿微量白蛋白、血肌酐水平单项及联合检测预测T2DM患者发生DN的价值。结果:发生组、未发生组血尿酸、尿微量白蛋白、血肌酐水平均高于对照组,且发生组高于未发生组,差异有统计学意义(P>0.05);ROC曲线分析结果显示,血尿酸、尿微量白蛋白、血肌酐水平单项及联合检测预测T2DM患者发生DN的曲线下面积分别为0.776、0.801、0.608、0.954,均具有一定预测价值,且联合检测诊断效能高于三者单项检测。结论:血尿酸、尿微量白蛋白、血肌酐水平联合检测预测T2DM患者发生DN的效能高于三者单项检测。 展开更多
关键词 2型糖尿病 糖尿病肾病 血尿酸 尿微量白蛋白 血肌酐 诊断
暂未订购
T2DM合并NAFLD患者血清内脂素、体成分和ACR变化及其与发生大血管并发症的关系研究
15
作者 李蕾 王欢欢 +2 位作者 宋利革 冯培红 康志强 《实用肝脏病杂志》 2026年第1期57-60,共4页
目的研究2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)患者血清内脂素、体成分和尿微量白蛋白/肌酐比值(ACR)变化及其与大血管并发症发生的关系。方法2022年1月~2025年1月我院诊治的237例T2DM患者,其中合并NAFLD患者122例,使用人体成... 目的研究2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)患者血清内脂素、体成分和尿微量白蛋白/肌酐比值(ACR)变化及其与大血管并发症发生的关系。方法2022年1月~2025年1月我院诊治的237例T2DM患者,其中合并NAFLD患者122例,使用人体成分分析仪检测腹部脂肪和内脏脂肪,估算内脏脂肪面积,常规检测尿微量白蛋白和肌酐,计算ACR,采用ELISA法检测血清内脂素。应用二元Logistic回归模型分析T2DM合并NAFLD患者发生大血管并发症的危险因素。结果合并NAFLD组血压、体质指数(BMI)和腰围均显著高于或大于T2DM(P<0.05);合并NAFLD组血清内脂素、腹部脂肪、内脏脂肪、内脏脂肪面积和ACR分别为(35.8±8.6)ng/mL、(8.9±2.3)kg、(2.9±0.8)kg、(91.8±20.6)cm^(2)和(29.6±6.8)mg/g,均显著高于T2DM组【分别为(20.7±5.4)ng/mL、(7.1±1.4)kg、(2.2±0.7)kg、(64.5±12.4)cm^(2)和(21.2±5.1)mg/g,P<0.05】;在本组122例T2DM合并NAFLD患者中发生大血管病变者31例(25.4%);发生大血管并发症组BMI、腰围、血清内脂素、腹部脂肪和ACR均显著大于未发生者(P<0.05);二元Logistic回归分析显示,BMI高(OR=3.108)、血清内脂素水平高(OR=4.187)和ACR高(OR=4.362)均是T2DM合并NAFLD患者发生大血管病变的危险因素(P<0.05)。结论T2DM合并NAFLD患者容易发生大血管病变,血清内脂素、体成分和ACR是危险因素。监测这些指标,可能有助于早期发现,并给予适当的检查和干预。 展开更多
关键词 非酒精性脂肪性肝病 2型糖尿病 内脂素 体成分 尿微量白蛋白/肌酐比值 大血管病变
暂未订购
达格列净对T2DN患者血流动力学及肾功能指标的影响
16
作者 刘豪健 李瑛 +1 位作者 张睿智 邬宏纪 《中国药物应用与监测》 2026年第3期387-390,共4页
目的探讨达格列净对2型糖尿病肾病(T2DN)患者肾脏血流动力学及肾功能指标的影响。方法采用回顾性队列研究方法,从电子病历系统采集2023年1月至2024年12月舟山市普陀区人民医院收治的92例T2DN患者的临床资料,分为暴露组(49例)与非暴露组... 目的探讨达格列净对2型糖尿病肾病(T2DN)患者肾脏血流动力学及肾功能指标的影响。方法采用回顾性队列研究方法,从电子病历系统采集2023年1月至2024年12月舟山市普陀区人民医院收治的92例T2DN患者的临床资料,分为暴露组(49例)与非暴露组(43例),非暴露组口服盐酸二甲双胍片,暴露组口服达格列净片,均治疗12周。比较暴露组和非暴露组疗效、血糖指标、肾功能指标及肾脏血流动力学评估参数[血管阻力指数(RI)]。结果暴露组总有效率高于非暴露组[87.76%(43/49)vs 60.47%(26/43),χ^(2)=9.097,P=0.003]。治疗后,暴露组空腹血糖、糖化血红蛋白均低于非暴露组[(6.83±0.92)mmol/L vs(8.15±1.24)mmol/L,t=5.843,P<0.001;(6.70±0.75)%vs(7.89±0.98)%,t=6.584,P<0.001],肾小球滤过率较非暴露组改善[(108.42±15.63)mL/min vs(119.25±12.71)mL/min,t=3.614,P<0.001];治疗后,暴露组血尿素氮、血肌酐、尿蛋白/肌酐及尿蛋白均较非暴露组降低[(4.97±0.82)mmol/L vs(5.36±0.88)mmol/L,t=2.200,P=0.030;(75.55±8.43)μmol/L vs(81.26±8.57)μmol/L,t=3.216,P=0.002;(0.18±0.03)g/24 h vs(0.22±0.05)g/24 h,t=4.717,P<0.001;(21.09±3.61)g/mol vs(25.17±3.35)g/mol,t=5.593,P<0.001]。在肾脏血流动力学方面,与非暴露组比较,暴露组治疗后的RI更低[(0.58±0.07)vs(0.62±0.09),t=2.394,P=0.019]。结论达格列净可改善T2DN患者肾脏RI,降低高滤过状态,减少尿蛋白排泄,保护肾功能,疗效优于二甲双胍。 展开更多
关键词 达格列净 2型糖尿病肾病 肾脏血流动力学 血管阻力指数 肾小球滤过率 尿蛋白/肌酐
暂未订购
血清NGAL、GDF-15和尿IGFBP-2水平对ASTEMI患者PCI术后发生造影剂肾病的预测价值
17
作者 吉鹏 颜永进 顾顺忠 《中国急救复苏与灾害医学杂志》 2026年第1期22-25,47,共5页
目的探讨血清中性粒细胞明胶酶相关载脂蛋白(NGAL)、生长分化因子15(GDF-15)及尿胰岛素样生长因子结合蛋白(IGFBP)2水平对急性ST段抬高型心肌梗死(ASTEMI)患者经皮冠状动脉介入(PCI)术后发生造影剂肾病(CIN)的预测价值。方法回顾性分析2... 目的探讨血清中性粒细胞明胶酶相关载脂蛋白(NGAL)、生长分化因子15(GDF-15)及尿胰岛素样生长因子结合蛋白(IGFBP)2水平对急性ST段抬高型心肌梗死(ASTEMI)患者经皮冠状动脉介入(PCI)术后发生造影剂肾病(CIN)的预测价值。方法回顾性分析2019年12月—2023年12月在海安市人民医院心血管内科行PCI治疗的ASTEMI患者108例,根据ASTEMI患者术后72 h发生CIN结局分为肾损伤组和非肾损伤组,比较两组的血清NGAL、GDF-15及尿IGFBP-2水平,分析血清NGAL、GDF-15及尿IGFBP-2对ASTEMI患者PCI术后发生CIN的影响,评估血清NGAL、GDF-15及尿IGFBP-2水平对ASTEMI患者PCI术后发生CIN的预测价值。结果108例接受PCI治疗的ASTEMI患者中发生CIN 16例。肾损伤组患者的左室射血分数低于非肾损伤组,血清△NGAL、血清△GDF-15及尿△IGFBP-2高于非肾损伤组(t=2.808、5.311、15.684、7.492,均P<0.05)。血清△NGAL(OR=2.206,95%CI:1.622~2.991)、血清△GDF-15(OR=2.237,95%CI:1.645~3.033)及尿△IGFBP-2(OR=3.130,95%CI:2.302~4.243)是ASTEMI患者PCI术后发生CIN的危险因素(均P<0.05)。血清NGAL、GDF-15及尿IGFBP-2单一及联合预测ASTEMI患者PCI术后发生CIN的灵敏度分别为0.72、0.75、0.63、0.87,特异度分别为0.74、0.71、0.78、0.69,曲线下面积分别为0.802(95%CI:0.723~0.891)、0.805(95%CI:0.731~0.896)、0.781(95%CI:0.674~0.863)、0.874(95%CI:0.808~0.941)。结论PCI前后血清NGAL、GDF-15及尿IGFBP-2的变化量可有效预测ASTEMI患者PCI术后CIN风险,联合预测效能最佳。 展开更多
关键词 急性ST段抬高型心肌梗死 经皮冠状动脉介入 造影剂肾病 中性粒细胞明胶酶相关载脂蛋白 生长分化因子15 尿胰岛素样生长因子结合蛋白2
暂未订购
2型糖尿病合并桥本甲状腺炎患者甲状腺过氧化物酶抗体与肾功能损伤相关性的研究 被引量:1
18
作者 张文龙 叶鹏 《中国糖尿病杂志》 北大核心 2025年第4期259-263,共5页
目的 探讨T2DM合并甲状腺功能正常的桥本甲状腺炎(HT)患者甲状腺过氧化物酶抗体(TPO-Ab)与肾功能损伤的相关性。方法 回顾性分析2020年1月至2022年12月成都市第二人民医院住院治疗的新诊断T2DM患者180例,根据是否合并HT分为单纯T2DM组(n... 目的 探讨T2DM合并甲状腺功能正常的桥本甲状腺炎(HT)患者甲状腺过氧化物酶抗体(TPO-Ab)与肾功能损伤的相关性。方法 回顾性分析2020年1月至2022年12月成都市第二人民医院住院治疗的新诊断T2DM患者180例,根据是否合并HT分为单纯T2DM组(n=75)和合并HT但甲状腺功能正常的HT组(n=105),比较两组临床特征、UACR、eGFR等生化指标,采用Pearson或Spearman相关分析UACR、eGFR与其他生化指标的相关性,采用多元线性回归分析UACR、eGFR的影响因素。结果 HT组UACR高于T2DM组[22.72(17.46,43.45)vs 20.60(14.67,27.32)mg/g,P<0.05],eGFR低于T2DM组[(87.47±14.61)vs(94.64±10.32)ml/(min·1.73 m^(2)),P<0.05]。相关分析显示,TPO-Ab与UACR呈正相关(r=0.376,P<0.05),与eGFR呈负相关(r=-0.354,P<0.05)。多元线性回归分析提示,TPO-Ab是UACR、eGFR的影响因素。结论 TPO-Ab是T2DM肾功能损伤影响因素,HT可能通过TPO-Ab加重T2DM患者肾功能损伤。 展开更多
关键词 糖尿病 2 桥本甲状腺炎 过氧化物酶抗体 尿微量白蛋白/肌酐比值 估算肾小球滤过率
原文传递
CO_(2)激光联合盆底磁电治疗女性压力性尿失禁的疗效观察 被引量:3
19
作者 刘睿 吕小娟 +2 位作者 肖倩格 赵璇 唐佳松 《中国妇幼保健》 2025年第4期611-616,共6页
目的探讨CO_(2)点阵激光联合盆底磁电治疗女性轻中度压力性尿失禁(SUI)的临床治疗效果。方法选取门诊110例SUI患者,随机分为3组,盆底磁电治疗组40例(对照组1)、CO_(2)点阵激光治疗组35例(对照2组)及CO_(2)点阵激光联合对照1组35例(观察... 目的探讨CO_(2)点阵激光联合盆底磁电治疗女性轻中度压力性尿失禁(SUI)的临床治疗效果。方法选取门诊110例SUI患者,随机分为3组,盆底磁电治疗组40例(对照组1)、CO_(2)点阵激光治疗组35例(对照2组)及CO_(2)点阵激光联合对照1组35例(观察组)。采用尿失禁影响问卷简表(IIQ-7)和盆腔器官脱垂-尿失禁性生活问卷简表(PISQ-12)对3组患者在接受治疗前后的主观疗效进行评价;采用1 h尿垫试验、Glazer评估及阴道健康指数评分表对3组患者在接受治疗前后的客观疗效进行评价。结果3组患者治疗均有效,治疗后PISQ-12、IIQ-7评分、阴道健康指数评分、1 h尿垫试验及Glazer评估均较治疗前得到改善(P<0.05);与对照1组、对照2组比较,CO_(2)点阵激光联合磁电治疗组效果增加更显著(P<0.05)。结论CO_(2)点阵激光联合盆底磁电治疗轻中度女性SUI具有更好的临床疗效,是一种有效的非手术治疗方法。 展开更多
关键词 压力性尿失禁 CO_(2)点阵激光 盆底磁电治疗
原文传递
CO_(2)腔内激光联合盆底磁刺激对女性压力性尿失禁患者盆底肌表面肌电值及盆底三维超声参数的影响 被引量:1
20
作者 侯涛 陈莉 +6 位作者 何珊 周萍 钟绮君 李晓辉 赵花 陈洋 郭燕媚 《中国医学装备》 2025年第5期87-92,共6页
目的:探讨CO_(2)腔内激光联合盆底磁刺激对女性压力性尿失禁(FSUI)患者盆底肌表面肌电值(sEMG)及盆底三维超声参数的影响。方法:选取2021年10月至2023年7月梅州市人民医院门诊收治的92例FSUI患者进行前瞻性研究,采用随机数表法将其分为... 目的:探讨CO_(2)腔内激光联合盆底磁刺激对女性压力性尿失禁(FSUI)患者盆底肌表面肌电值(sEMG)及盆底三维超声参数的影响。方法:选取2021年10月至2023年7月梅州市人民医院门诊收治的92例FSUI患者进行前瞻性研究,采用随机数表法将其分为观察组和对照组,每组46例。两组均给予居家盆底肌锻炼,在此基础上对照组给予盆底磁刺激治疗,观察组在对照组基础上加用CO_(2)腔内激光治疗。比较两组患者的漏尿情况(1 h尿垫实验,12 h漏尿次数)、治疗疗效中盆底肌sEMG、盆底三维超声参数和有关生活质量和性生活质量的国际尿失禁咨询委员会尿失禁问卷简表(ICIQ-SF)、尿失禁影响问卷简版(IIQ-7)以及盆腔器官脱垂-尿失禁性生活问卷(PISQ-12)评分。结果:观察组1 h漏尿量为0,少于对照组的3 g,差异有统计学意义(Z=-2.866、-2.355,P<0.05),两组24 h漏尿次数均为0次。观察组治疗总有效率为95.65%,高于对照组的58.70%,差异有统计学意义(χ^(2)=4.083,P<0.05)。治疗后,两组患者盆底肌sEMG的快速收缩最大值、紧张收缩均值和耐力收缩均值均增加,且观察组增加更多,分别为(40.78±3.28)、(31.56±4.20)和(29.34±2.58)μV;对照组治疗后增加的数据分别为(35.17±5.10)、(25.87±3.82)和(25.37±2.67)μV,两组比较差异均有统计学意义(t=6.275、6.797、7.252,P<0.05)。治疗后,两组Valsalva动作时膀胱颈移动度(BND)、膀胱颈距耻骨联合后下缘距离(BSD)、尿道旋转角(URA)以及膀胱尿道后角(RVA)均减小,且观察组减小更多,分别为(24.30±3.21)和(2.34±0.23)mm、(56.40±5.87)°和(89.54±9.21)°;对照组治疗后的数据分别为(26.21±3.48)和(3.57±0.35)mm、(60.29±6.45)°和(126.71±13.50)°,两组比较差异均有统计学意义(t=2.736、19.919、3.025、15.426,P<0.05)。治疗后,两组ICIQ-SF、IIQ-7评分均降低,PISQ-12评分均升高,且观察组改善效果更优,差异有统计学意义(t=11.478、13.168、6.631,P<0.05)。结论:在盆底肌锻炼基础上,CO_(2)腔内激光联合盆底磁刺激能够缓解FSUI患者尿失禁症状,提升疗效,改善盆底肌力和盆底支撑结构的稳定性,提升生命质量和性生活质量。 展开更多
关键词 CO_(2)腔内激光 盆底磁刺激 女性压力性尿失禁 表面肌电值 三维超声参数
暂未订购
上一页 1 2 45 下一页 到第
使用帮助 返回顶部